Our Mission
Avenue is focused on delivering impactful therapies to patients suffering from neurologic diseases. We believe our unique pipeline of innovative treatments has the potential to overcome limitations of existing treatment options and ultimately transform patient outcomes.
Overview
Avenue Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases. The Company is advancing a diverse portfolio that includes first-in-class and best-in-class programs in a high-value neurologic landscape with significant unmet patient need.
OPEN CORPORATE PRESENTATION
Recent News
November 14, 2024:
Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights